Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olinger, C. P.
Right arrow Articles by Marler, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olinger, C. P.
Right arrow Articles by Marler, J. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NALOXONE

Stroke, Vol 21, 721-725, Copyright © 1990 by American Heart Association


ARTICLES

High-dose intravenous naloxone for the treatment of acute ischemic stroke

CP Olinger, HP Adams Jr, TG Brott, J Biller, WG Barsan, GJ Toffol, RW Eberle and JR Marler
Department of Neurology, University of Cincinnati, Ohio.

To evaluate the safety and possible efficacy of high-dose naloxone for the treatment of acute cerebral ischemia, 38 patients received a loading dose of 160 mg/m2 over 15 minutes followed by a 24-hour infusion at the rate of 80 mg/m2/hr. Nausea and/or vomiting were common side effects. Naloxone was discontinued in seven patients (because of hypotension in one, bradycardia and hypotension in two, myoclonus in one, focal seizures in two, and hypertension in one); all seven patients responded to treatment and no permanent sequelae to naloxone were noted. Twelve of the 38 patients showed early neurologic improvement (by completion of the naloxone loading dose). However, there was no correlation between such a loading dose response and clinical outcome at 3 months. Our experience suggests that naloxone is safe at the dose used, but data for efficacy are inconclusive.


This article has been cited by other articles:


Home page
CirculationHome page
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al.
Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Circulation, May 22, 2007; 115(20): e478 - e534.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al.
Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists
Stroke, May 1, 2007; 38(5): 1655 - 1711.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Boutin, F. Dauphin, E. T. MacKenzie, P. Jauzac, and R. C. Koehler
Differential Time-Course Decreases in Nonselective, µ-, {delta}-, and {kappa}-Opioid Receptors After Focal Cerebral Ischemia in Mice • Editorial Comment
Stroke, June 1, 1999; 30(6): 1271 - 1278.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S.-M. Lai, P. W. Duncan, and J. Keighley
Prediction of Functional Outcome After Stroke : Comparison of the Orpington Prognostic Scale and the NIH Stroke Scale
Stroke, September 1, 1998; 29(9): 1838 - 1842.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
J. C Grotta
Prevention and management of stroke
Vascular Medicine, March 1, 1991; 2(1): 3 - 17.
[PDF]